Kioxia Holdings ¥120.4 billion IPO
The shares are listed on the Tokyo Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Sanrio ¥135.1 billion secondary offering
The shares are listed on the Tokyo Stock Exchange
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
Rakuten Group $550 million subordinated notes offering
The 8.125% reset notes are listed on the Singapore Exchange
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
SP Group Treasury GMTN update and $700 million notes offering
The notes are due 2029
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Rigaku Holdings ¥129.1 billion IPO
The shares are listed on the Tokyo Stock Exchange
Amer Sports $1.05 billion follow-on offering
We advised Amer Sports on its SEC-registered offering
Laekna HK$236 million placement of shares
We advised Laekna on the placement of new shares